The Administrative Core Director: Angela M. Gronenborn, PhD will have the primary responsibility for directing and exciting the research and programs of the proposed PCHPI. Dr. Gronenborn has directed research groups for the last 30 years, first at the MRC in London, UK, then at the Max-Planck-institute for Biochemistry in Munich, Germany, and, from 1988-2006, at the NIH in Bethesda. She has overseen the work of technical personnel, students, post-docs and permanent scientific staff. She will direct the implementation of the collaborative framework among the cores and between the cores and research projects (both in-house and external). In addition. Dr. Gronenborn will attend the annual meetings of the NIGMS appointed network advisory committee and the annual scientific meeting. Dr. Gronenborn will prepare annual updates to the PCHPI's plans for collaboration (guided by the Executive Committee) and provide these to the Advisory Committee. In addition, the Director along with the Center Coordinator will have the primary responsibility for ensuring that all aspects of the center function smoothly. Dr. Gronenborn will chair the Executive Committee. Center Coordinator: Teresa Brosenitsch, PhD will serve as the Center Coordinator. Dr. Brosenitsch has been a part of the PCHPI since its inception and will continue to oversee the day-to-day operation of the center and communication among members and collaborators. With help from Dr. Gronenborn's administrative assistant. Dr. Brosenitsch will ensure that meetings, teleconferences, and educational programs occur as outlined and will oversee the logistics for workshop and seminar implementation, including travel arrangements. Dr. Brosenitsch will also coordinate all educational and collaboration promotion activities, including the Collaboration Development Program solicitation, application, and review processes. Dr. Brosenitsch reports directly to Dr. Gronenborn and will oversee implementation and coordination of the directives and policies of the Executive Committee. She will be a member of the Executive Committee. The Director and the Center Coordinator will have regularly scheduled meetings on a bi-weekly basis. Dr. Brosenitsch will work closely with the staff of the Department of Structural Biology, including an administrative assistant, the business manager, and IT personnel, to carry out the activities of the core. Executive Committee: The Executive Committee will be composed of the Center Director, the Center Coordinator, each of the core directors, and the leaders of each of project. It will meet on a monthly schedule and will define research priorities, strategize as to how to overcome technical problems and bottlenecks, analyze center progress and adherence to project timelines, provide oversight of PCHPI finances, establish and implement educational and training programs, provide oversight of the PCHPIs'web server content, and strategize about how to promote collaboration. Scientific Advisory Board (SAB): A Scientific Advisory Board will be appointed in consultation with and subject to approval of the NIGMS. The SAB will have at least three external advisors, including a virologist and a structural biologist, to be appointed by the Executive Committee through nominations and voting. The SAB will meet annually to review the center's progress toward milestones (as outlined in the Section 1, Approach), provide direction for defining new structural targets, and discuss strategies to improve progress. The advice of the SAB will play an important role on decisions related to project continuation or cessation (see below). The SAB will be asked to provide a written summary of their critique within a month of their visit. This critique and the PCHPI's response will be provided to the NIGMS program official. The NIGMS program official will be invited to attend all meetings of the PCHPI SAB. Consultant: Dr. Ronald Montelaro, co-Director of the PCHPI during the first five years of PCHPI funding will serve as a consultant on administrative matters, applying his extensive knowledge and experience in the HIV-l field, to help set research and collaboration priorities.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
5P50GM082251-08
Application #
8727029
Study Section
Special Emphasis Panel (ZRG1-AARR-K)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
8
Fiscal Year
2014
Total Cost
$2,139,855
Indirect Cost
$263,915
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Gupta, Rupal; Lu, Manman; Hou, Guangjin et al. (2016) Dynamic Nuclear Polarization Enhanced MAS NMR Spectroscopy for Structural Analysis of HIV-1 Protein Assemblies. J Phys Chem B 120:329-39
Van Oss, S Branden; Shirra, Margaret K; Bataille, Alain R et al. (2016) The Histone Modification Domain of Paf1 Complex Subunit Rtf1 Directly Stimulates H2B Ubiquitylation through an Interaction with Rad6. Mol Cell 64:815-825
Perilla, Juan R; Gronenborn, Angela M (2016) Molecular Architecture of the Retroviral Capsid. Trends Biochem Sci 41:410-20
Sharaf, Naima G; Ishima, Rieko; Gronenborn, Angela M (2016) Conformational Plasticity of the NNRTI-Binding Pocket in HIV-1 Reverse Transcriptase: A Fluorine Nuclear Magnetic Resonance Study. Biochemistry 55:3864-73
Byeon, In-Ja L; Byeon, Chang-Hyeock; Wu, Tiyun et al. (2016) Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity. Biochemistry 55:2944-59
Saito, Akatsuki; Ferhadian, Damien; Sowd, Gregory A et al. (2016) Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74. J Virol 90:5808-23
Ning, Jiying; Erdemci-Tandogan, Gonca; Yufenyuy, Ernest L et al. (2016) In vitro protease cleavage and computer simulations reveal the HIV-1 capsid maturation pathway. Nat Commun 7:13689
Rasheedi, Sheeba; Shun, Ming-Chieh; Serrao, Erik et al. (2016) The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes. J Biol Chem 291:11809-19
Ramalho, Ruben; Rankovic, Sanela; Zhou, Jing et al. (2016) Analysis of the mechanical properties of wild type and hyperstable mutants of the HIV-1 capsid. Retrovirology 13:17
Oum, Yoon Hyeun; Desai, Tanay M; Marin, Mariana et al. (2016) Click labeling of unnatural sugars metabolically incorporated into viral envelope glycoproteins enables visualization of single particle fusion. J Virol Methods 233:62-71

Showing the most recent 10 out of 113 publications